<?xml version="1.0" encoding="UTF-8"?>
<ref id="B48-vaccines-07-00046">
 <label>48.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mamat</surname>
    <given-names>U.</given-names>
   </name>
   <name>
    <surname>Woodard</surname>
    <given-names>R.W.</given-names>
   </name>
   <name>
    <surname>Wilke</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Souvignier</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Mead</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Steinmetz</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Terry</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kovacich</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Zegers</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Knox</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>Endotoxin-free protein production—ClearColi™ technology (Application Note)</article-title>
  <source>Nature Methods</source>
  <year>2013</year>
  <volume>10</volume>
  <fpage>916</fpage>
  <pub-id pub-id-type="doi">10.1038/nmeth.f.367</pub-id>
 </element-citation>
</ref>
